News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
171 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39122)
2019 (51337)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42567)
2024 (37443)
2025 (33092)
2026 (8449)
Month
January (3098)
February (3516)
March (3513)
April (3269)
May (4089)
June (3205)
July (2932)
August (3176)
September (2859)
October (3385)
November (3129)
December (2245)
Day
1 (171)
2 (182)
3 (149)
4 (162)
5 (103)
8 (133)
9 (169)
10 (133)
11 (155)
12 (96)
15 (156)
16 (164)
17 (139)
18 (162)
19 (104)
22 (161)
23 (156)
24 (175)
25 (168)
26 (139)
29 (142)
30 (124)
31 (142)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
8
9
10
11
12
15
16
17
18
19
22
23
24
25
26
29
30
31
Biotech Bay
Preliminary Phase 1 Data for Exelixis, Inc.'s Cabozantinib in Japanese Patients Presented at ESMO 2012
October 1, 2012
·
1 min read
Business
C.R. Bard to Host Earnings Conference Call on October 23, 2012
October 1, 2012
·
1 min read
Biotech Bay
Interim Data for Exelixis, Inc.'s Cabozantinib 40 mg Dose Cohort in Metastatic Castration-Resistant Prostate Cancer Presented at ESMO 2012 Congress
October 1, 2012
·
1 min read
SafeStitch Medical, Inc. Announces Sales of the AMID Hernia Fixation Device
October 1, 2012
·
1 min read
Drug Development
AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) Announces Detailed Results of Exploratory Phase 2 Study Evaluating Ficlatuzumab in First-Line Patients With Advanced Non-Small Cell Lung Cancer; New Data Presented at ESMO
October 1, 2012
·
1 min read
Deals
Cardium Therapeutics, Inc. Announces the Acquisition of To Go Brands
October 1, 2012
·
9 min read
Biotech Bay
IntegenX Announces U.S. Launch of the RapidHIT 200 System - Rapid DNA Technology That Will Revolutionize the Use of DNA in Law Enforcement and Forensics
October 1, 2012
·
1 min read
Policy
Watson Pharmaceuticals, Inc. Confirms Favorable District Court Ruling in Androgel® 1% Antitrust Litigation
October 1, 2012
·
2 min read
Genetown
Biotech Support Group Release: Cleanascite Lipid Removal and Clarification Reagent for Alzheimer’s Disease Research
October 1, 2012
·
6 min read
Genetown
Vertex Pharmaceuticals (MA) Announces Presentation of New Data From Hepatitis C Development Program at American Association for Study of Liver Diseases Annual Meeting
October 1, 2012
·
1 min read
Previous
8 of 18
Next